OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex molecules. Improving these processes involves adjusting various variables, including cell line development, media formulation, and bioreactor conditions. A key goal is to amplify antibody yield while reducing production expens